Laatste proeven


EudraCT Number: 2008-003600-55 Sponsor Protocol Number: ALN-RSV01-106 Start Date:
Sponsor Name: Alnylam Pharmaceuticals, Inc.
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected ...
Medical condition: Lung transplant patients with Human respiratory syncytial virus (RSV) infection
Disease: Version SOC Term Classification Code Term Level
9.1 10052200 Respiratory syncytial virus infection NOS LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

EudraCT Number: 2007-005004-40 Sponsor Protocol Number: K/602 Start Date:
Sponsor Name: Cassella-med
Full Title: Multizentrischer, randomisierter, doppelblinder, Placebo-kontrollierter Parallelgruppenvergleich zum Nachweis der Wirksamkeit und Unbedenklichkeit von Chinin bei Patienten mit Fibromyalgie
Medical condition: Fibromyalgie
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)
EudraCT Number: 2010-022941-72 Sponsor Protocol Number: PMR-EC-1503 Start Date:
Sponsor Name: Astellas Pharma Europe Ltd.
Full Title: A MULTICENTER, TWO ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN STABLE HEART TRANSPLANT RECIPIENTS RECEIVING AN ADVAGRAF® BASED IMMUNOSUPPRESSIVE REGIMEN WITH OR WITHOUT ...
Medical condition: Prophylaxis of heart transplant rejection.
Disease: Version SOC Term Classification Code Term Level
12.1 10050432 Prophylaxis against heart transplant rejection LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Prematurely Ended) SK (Prematurely Ended) CZ (Prematurely Ended) ES (Prematurely Ended)
Trial results: View results

EudraCT Number: 2014-002465-30 Sponsor Protocol Number: EE-01bude2014 Start Date:
Sponsor Name: Dip. Pediatria UOC Gastroenterologia ed Epatologia Pediatrica
Full Title: Spontaneous study on the efficacy and safety of an oral viscous suspension of budesonide administered to children affected by eosinophilic esophagitis.
Medical condition: Eosinophilic Esophagitis
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2019-003395-39 Sponsor Protocol Number: MRX-503 Start Date:
Sponsor Name: Mirum Pharmaceuticals Inc.
Full Title: MRX-503: An Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Maralixibat in the Treatment of Subjects with Progressive Familial Intrahepatic Cholestasis (PFIC)
Medical condition: In patients with progressive familial intrahepatic cholestasis (PFIC), impairment of the egress of bile acids from the liver leads to cholestasis, hepatocellular injury and damage, and progressive ...
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10076033 Progressive familial intrahepatic cholestasis PT
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) BE (Ongoing) PL (Ongoing) FR (Ongoing) HU (Ongoing) AT (Ongoing) IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2010-022984-36 Sponsor Protocol Number: 201051 Start Date:
Sponsor Name: Santen Oy
Full Title: A phase III, randomized, double-masked 6-month clinical study to compare the efficacy and safety of the preservative-free fixed dose combination of tafluprost 0.0015% and timolol 0.5% eye drops to ...
Medical condition: Patients diagnosed with ocular hypertension or open-angle glaucoma (primary open-angle glaucoma [POAG], capsular glaucoma or pigmentary glaucoma).
Disease: Version SOC Term Classification Code Term Level
12.1 10030043 Ocular hypertension LLT
12.1 10036719 Primary open angle glaucoma LLT
12.1 10035015 Pigmentary glaucoma LLT
12.1 10037118 Pseudoexfoliation glaucoma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) LV (Completed) CZ (Completed) ES (Completed) PT (Completed) AT (Completed) BG (Completed)
Trial results: View results
EudraCT Number: 2017-000278-13 Sponsor Protocol Number: P16-07/BP052 Start Date:
Sponsor Name: BIOPROJET PHARMA
Full Title: Palatability testing in children of a new paediatric formulation of Racecadotril as oral suspension strawberry-flavored administered via an oral graduated syringe compared to the current formulatio...
Medical condition: Young healthy volunteers (7-12 years)
Disease: Version SOC Term Classification Code Term Level
19.1 100000004856 10055955 Acute diarrhoea LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: FR (Completed)
Trial results: (No results available)

EudraCT Number: 2010-021800-72 Sponsor Protocol Number: DB2113360 Start Date:
Sponsor Name: GlaxoSmithKline Research & Development Ltd
Full Title: DB2113360: A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GW642444 and with tiotropium over 24 weeks in subjects with COPD
Medical condition: subjects with COPD
Disease: Version SOC Term Classification Code Term Level
14.1 10038738 - Respiratory, thoracic and mediastinal disorders 10010952 COPD LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) PL (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2018-004009-22 Sponsor Protocol Number: WVE-DMDX51-003 Start Date:
Sponsor Name: Wave Life Sciences UK Limited
Full Title: A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 in Ambulatory Patients with Duchenne Muscular Dystrophy
Medical condition: Duchenne muscular dystrophy
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10013801 Duchenne muscular dystrophy PT
Population Age: Children, Adolescents, Under 18 Gender: Male
Trial protocol: FR (Ongoing) GB (Prematurely Ended) SE (Prematurely Ended) NL (Ongoing) BE (Prematurely Ended) PL (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended)
Trial results: View results

EudraCT Number: 2007-002455-16 Sponsor Protocol Number: LTGV550-PII-11/06 Start Date:
Sponsor Name: Laboratoires Théa
Full Title: Efficacy and safety of GV 550 in acute adenoviral keratoconjunctivitis
Medical condition: acute adenoviral keratoconjunctivitis
Disease: Version SOC Term Classification Code Term Level
9.1 10014975 Epidemic keratoconjunctivitis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)
3